Stay updated on Edwards Lifesciences Press Releases
Sign up to get notified when there's something new on the Edwards Lifesciences Press Releases page.

Latest updates to the Edwards Lifesciences Press Releases page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check189 days agoChange DetectedThe webpage has been updated with significant new information regarding Edwards Lifesciences, including upcoming earnings conference calls, recent sales, and clinical trial results, which highlight advancements in their medical technologies and products.SummaryDifference100%
- Check290 days agoChange DetectedThe latest update highlights the promising real-world outcomes of the Edwards’ SAPIEN 3 Ultra RESILIA Valve as of November 25, 2024, while previous announcements regarding the earnings conference call have been removed.SummaryDifference100%
- Check319 days agoChange DetectedRecent updates highlight significant advancements in heart treatment, including the TRISCEND II trial showcasing the benefits of the EVOQUE system for tricuspid regurgitation and new data on EARLY TAVR for asymptomatic aortic stenosis patients.SummaryDifference100%
- Check326 days agoChange DetectedEdwards Lifesciences has reported its third quarter results for 2024, while the previous announcement regarding the expansion of its structural heart portfolio through acquisitions has been removed.SummaryDifference100%
- Check333 days agoChange DetectedEdwards Lifesciences has announced an upcoming earnings conference call on October 24, 2024, while the previous report on second quarter results from July 24, 2024, has been removed.SummaryDifference100%
Stay in the know with updates to Edwards Lifesciences Press Releases
Enter your email address, and we'll notify you when there's something new on the Edwards Lifesciences Press Releases page.